E. Hammond

发表

A multiple wavelength algorithm in color image analysis and its applications in stain decomposition in microscopy images.

R. Zhou, E. Hammond, D. Parker, 1996, Medical physics.

Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

R. Bast, Nofisat Ismaila, Minetta C. Liu, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy.

M. Somerfield, R. Schilsky, S. Hamilton, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The intermediate layer: a morphologic study of the elastin and hyaluronic acid constituents of normal human vocal folds.

R. Zhou, E. Hammond, S. Gray, 1997, Journal of voice : official journal of the Voice Foundation.

Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma.

Ruth Katz, K. Fu, E. Hammond, 2002, Cancer research.

Consensus Recommendations on Estrogen Receptor Testing in Breast Cancer By Immunohistochemistry

Clive R Taylor, Clive R. Taylor, Stephen M Hewitt, 2008, Applied immunohistochemistry & molecular morphology : AIMM.

Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population

Daniel J Brat, Cynthia Cohen, Erwin G. Van Meir, 2004, Cancer Research.

Benign Pathologic Responses of the Larynx

E. Hammond, S. Gray, D. Hanson, 1995 .

Vascular rejection in heart transplantation: clinical correlation, treatment options, and future considerations.

D. Renlund, E. Hammond, M. Bristow, 1993, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Predictive Markers of Breast Cancer: ER, PR, and HER2

E. Hammond, D. Hicks, J. Prichard, 2011 .

Correlation of survival with quantitative tissue staining of prostate specific acid phosphatase in patients with prostate carcinoma by using microscopic image analysis: a preliminary report of correlative studies on RTOG protocols 75-06, 77-06, and 83-07.

P. Rubin, W. Sause, R. Zhou, 1995, International journal of radiation oncology, biology, physics.

HLA A, B and DR typing in idiopathic dilated cardiomyopathy: a search for immune response factors.

J. Carlquist, E. Hammond, J. Anderson, 1984, The American journal of cardiology.

Gastrointestinal stromal tumor of the duodenum: a case report.

E. Hammond, R. Flinner, 1991, Ultrastructural pathology.

Core vs Breast Resection Specimen: Does It Make a Difference for HER2 Results?

E. Hammond, P. Fitzgibbons, D. Hicks, 2015, American journal of clinical pathology.

ASCO Provisional Clinical Opinion: KRAS, Cetuximab, and Panitumumab-Clinical Implications in Colorectal Cancer.

E. Hammond, R. Morton, 2009, Journal of oncology practice.

Clinically relevant breast cancer reporting: using process measures to improve anatomic pathology reporting.

E. Hammond, R. Flinner, 1997, Archives of pathology & laboratory medicine.

Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart.

Dean Y. Li, D. Renlund, A. Kfoury, 2010, Journal of the American College of Cardiology.

Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor (VEGF) negatively affect overall survival in carcinoma of the cervix treated with radiotherapy.

E. Hammond, J. Holden, D. Gaffney, 2003, International journal of radiation oncology, biology, physics.

Active surveillance for prostate cancer: the role of the pathologist.

M. Rubin, A. Chinnaiyan, B. Delahunt, 2015, Pathology.

Is advanced age a barrier to effective cancer treatment? The experience of nonagenarians receiving radiation therapy

E. Hammond, He Gao, M. Back, 2012, Asia-Pacific journal of clinical oncology.

Evaluation of MDM2, p16, and p53 staining levels as biomarkers of biochemical recurrence following salvage radiation therapy for recurrent prostate cancer

M. Heckman, T. Pisansky, E. Hammond, 2012, The Prostate.

Left ventricular mass increases during cardiac allograft vascular rejection.

D. Renlund, E. Hammond, E. Gill, 1995, Journal of the American College of Cardiology.

College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Report of the Prostate Cancer Working Group.

D. Grignon, E. Hammond, 1995, Archives of pathology & laboratory medicine.

Antilymphocyte-antibody prophylaxis: review of the adult experience in heart transplantation.

D. Renlund, A. Kfoury, E. Hammond, 1997, Transplantation proceedings.

The first pediatric Japanese case to undergo heart transplantation in the Utah Cardiac Transplant Program in the United States.

D. Renlund, E. Hammond, K. Umetani, 1993, Japanese circulation journal.

Cyclooxygenase-2 (COX-2) and Epidermal Growth Factor Receptor (EGFR) Expression in Human Pituitary Macroadenomas

W. Curran, T. Hyslop, A. Dicker, 2003, American journal of clinical oncology.

Utility of immunofluorescence and electron microscopy in endomyocardial biopsies from patients with unexplained heart failure.

Rosemary C. She, E. Hammond, R. She, 2010, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

OKT3 monoclonal antibody in heart transplantation.

D. Renlund, E. Hammond, M. Bristow, 1988, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Predictive value of immunofluorescence and electron microscopic evaluation of endomyocardial biopsies in the diagnosis and prognosis of myocarditis and idiopathic dilated cardiomyopathy.

E. Hammond, J. Anderson, R. Menlove, 1987, American heart journal.

The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3).

D. Renlund, E. Hammond, M. Bristow, 1996, Transplantation.

Relationship of OKT3 sensitization and vascular rejection in cardiac transplant patients receiving OKT3 rejection prophylaxis.

D. Renlund, E. Hammond, C. Craven, 1990, Transplantation.

Allograft coronary artery disease: clinical correlations with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection.

D. Renlund, A. Kfoury, E. Hammond, 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Utility of ultrastructural studies of cardiac biopsy specimens.

E. Hammond, 1994, Ultrastructural pathology.

Ultrastructural findings in cardiac transplant recipients.

E. Hammond, R. Yowell, 1994, Ultrastructural pathology.

Immunohistochemical analysis of platelet-derived growth factor and basic fibroblast growth factor in cardiac biopsy and autopsy specimens of heart transplant patients.

E. Hammond, R. Shaddy, R. Yowell, 1996, The American journal of cardiology.

Effect of blood product transfusion-induced tolerance on incidence of cardiac allograft rejection.

B. Horne, A. Kfoury, E. Hammond, 2010, Transplantation proceedings.

Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy.

D. Lappé, D. Renlund, E. Hammond, 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

THE USE OF MYCOPHENOLATE MOFETIL (RS‐61443) IN HUMAN HEART TRANSPLANT RECIPIENTS

D. Renlund, E. Hammond, M. Bristow, 1993, Transplantation.

OUTCOME OF CARDIAC TRANSPLANT RECIPIENTS WITH A POSITIVE DONOR‐SPECIFIC CROSSMATCH—PRELIMINARY RESULTS WITH PLASMAPHERESIS

D. Renlund, E. Hammond, W. Richenbacher, 1992, Transplantation.

Antimurine antibody to OKT3 in cardiac transplantation: implications for prophylaxis and retreatment of rejection.

D. Renlund, E. Hammond, M. Bristow, 1991, Transplantation proceedings.

Correlation between epidermal growth factor receptor family (HER1, HER2, HER3, HER4), phosphorylated akt (P-AKT) and clinical outcomes after radiation therapy in carcinoma of the cervix

E. Hammond, D. Shrieve, D. Gaffney, 2004 .

Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications.

D. Renlund, E. Hammond, M. Bristow, 1989, The Journal of heart transplantation.

DEFICIENT NATURAL KILLER CELL ACTIVITY IN PATIENTS WITH IDIOPATHIC DILATED CARDIOMYOPATHY

J. Carlquist, Jeffrey L. Anderson, E. Hammond, 1982, The Lancet.

Myocardial apoptosis in a heterotopic murine heart transplantation model of chronic rejection and graft vasculopathy.

S. Perkins, M. Trautman, E. Hammond, 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Immunoglobulin G fractions from patients with antiphospholipid antibodies cause fetal death in BALB/c mice: a model for autoimmune fetal loss.

M. Mitchell, E. Hammond, D. Branch, 1990, American journal of obstetrics and gynecology.

Pathology of Cardiac Allograft Vascular (Microvascular) Rejection: Impact on Patient Outcomes

D. Renlund, E. Hammond, R. Yowell, 2001 .

Pathology of Cardiac Allograft Rejection. 1: Vascular (Microvascular)

E. Hammond, 1996 .

Vascular rejection in cardiac transplantation: Histologic, immunopathologic, and ultrastructural features.

E. Hammond, C. Craven, R. Yowell, 1993, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

A PROSPECTIVE, RANDOMIZED COMPARISON OF CYCLOPHOSPHAMIDE AND AZATHIOPRINE FOR EARLY REJECTION PROPHYLAXIS AFTER CARDIAC TRANPLANTATION DECREASED SENSITIZATION TO OKT3

D. Renlund, E. Hammond, M. Bristow, 1994, Transplantation.

Sensitization to OKT3 monoclonal antibody in heart transplantation: correlation with early allograft loss.

D. Renlund, E. Hammond, C. Wittwer, 1991, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Clinical manifestations of vascular rejection in cardiac transplantation.

D. Renlund, E. Hammond, M. Bristow, 1991, Transplantation proceedings.

The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation.

A. Angelini, G. Berry, M. Fishbein, 2013, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Antibody-Mediated Rejection and Early Cardiac Allograft Vasculopathy in a Child With Congenital Heart Disease

E. Hammond, M. Revelo, Dylan V. Miller, 2012 .

Longitudinal evaluation of microvessel density in survivors vs. nonsurvivors of cardiac pathologic antibody-mediated rejection.

A. Kfoury, E. Hammond, M. Revelo, 2012, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

Coronary artery vasospasm causing acute myocardial infarction in a heart transplant recipient.

E. Hammond, J. Bisognano, J. Lindenfeld, 2005, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Mechanical Circulatory Support Multivariate Predictors of Heart Transplantation Outcomes in the Era of Chronic

B. Horne, A. Kfoury, E. Hammond, 2013 .

Vascular rejection and its relationship to allograft coronary artery disease.

E. Hammond, M. Bristow, D. Doty, 1992, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Neuroendocrine carcinomas: role of immunocytochemistry and electron microscopy.

E. Hammond, R. Flinner, R. Yowell, 1998, Human pathology.

Protocol for the examination of specimens from patients with primary cardiac tumors: a basis for checklists. Cancer Committee, College of American Pathologists.

E. Hammond, 2009, Archives of pathology & laboratory medicine.

Combined modality program with possible organ preservation for invasive bladder carcinoma: results of RTOG protocol 85-12.

E. Hammond, S. Asbell, J. Heaney, 1993, International journal of radiation oncology, biology, physics.

A human endometrial explant system: validation and potential applications.

M. Mitchell, E. Hammond, D. Branch, 1992, American journal of obstetrics and gynecology.

Diagnostic and Prognostic Value of Immunofluorescence and Electron-Microscopic Findings in Idiopathic Dilated Cardiomyopathy

Jeffrey L. Anderson, E. Hammond, R. Menlove, 1990 .

Immunofluorescence Microscopy in the Diagnosis and Follow-up of Patients Suspected of Having Inflammatory Heart Disease

Jeffrey L. Anderson, E. Hammond, R. Menlove, 1988 .

Comparison of sympathetic innervation of failing and nonfailing human hearts by quantitative evaluation of catecholamine fluorescence

E. Hammond, M. Bristow, P. Larrabee, 1991 .

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant.

A. Kfoury, G. Stoddard, O. Wever-Pinzon, 2016, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Head and neck cancer committee

R. Weber, F. Khuri, T. Pajak, 2001 .

Immunocytochemical Study of Proteoglycans in Vocal Folds

E. Hammond, S. Gray, T. Hammond, 1996, The Annals of otology, rhinology, and laryngology.

Cyclooxygenase-2 (COX-2) Expression in Human Meningioma as a Function of Tumor Grade

W. Curran, T. Hyslop, A. Dicker, 2003, American journal of clinical oncology.

The diagnosis of thymoma: a review.

E. Hammond, R. Flinner, 1991, Ultrastructural pathology.

Age- and gender-related elastin distribution changes in human vocal folds

R. Zhou, E. Hammond, S. Gray, 1998 .

Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection.

D. Renlund, E. Hammond, C. Craven, 1991, Transplantation proceedings.

Long-term follow-up after radical prostatectomy. Identification of prognostic variables.

E. Hammond, J. Smith, J. Avent, 1991, The Urologic clinics of North America.

Acute vascular rejection involving the major coronary arteries of a cardiac allograft.

D. Renlund, E. Hammond, M. Bristow, 1988, The Journal of heart transplantation.

Clinical use of the total artificial heart.

E. Hammond, J. Anderson, L. Joyce, 1984, The New England journal of medicine.

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model.

J. Carlquist, J. Muhlestein, E. Hammond, 1998, Circulation.

Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.

D. Lappé, D. Renlund, E. Hammond, 1996, Clinical transplantation.

Primary culture of cells arising from a neuroendocrine skin carcinoma.

E. Hammond, K. B. English, N. Stayner, 1990, The American Journal of dermatopathology.

Cell cycle blockade and differentiation of ovarian cancer cells by the histone deacetylase inhibitor trichostatin A are associated with changes in p21, Rb, and Id proteins.

E. Hammond, K. Strait, B. Dabbas, 2002, Molecular cancer therapeutics.

Quantitation of prostate-specific acid phosphatase in prostate cancer: reproducibility and correlation with subjective grade.

P. Rubin, W. Sause, R. Zhou, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Protocols for the examination of tumors of diverse sites: introduction. Cancer Committee, College of American Pathologists.

C C Compton, C. Compton, E. Hammond, 1999, Archives of pathology & laboratory medicine.

Strategic plans to promote head and neck cancer translational research within the radiation therapy oncology group: a report from the translational research program.

K. Ang, P. Harari, C. Chung, 2007, International journal of radiation oncology, biology, physics.

A murine model of preterm labor: inflammatory mediators regulate the production of prostaglandin E2 and interleukin-6 by murine decidua.

M D Mitchell, M. Mitchell, E. Hammond, 1993, Biology of reproduction.

Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad

E. Hammond, K. Strait, S. Ilstrup, 2005, Molecular Cancer Therapeutics.

Prognostic value of survivin in locally advanced prostate cancer: study based on RTOG 8610.

Min Zhang, H. Sandler, Yoshiyuki Suzuki, 2005, International journal of radiation oncology, biology, physics.

Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.

R. Jove, J. Torres-Roca, H. Sandler, 2007, Urology.

Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist

M. Rubin, A. Chinnaiyan, B. Delahunt, 2014, Virchows Archiv.

PREVENTION OF Pneumocystis carinii PNEUMONIA IN CARDIAC TRANSPLANT RECIPIENTS BY TRIMETHOPRIM SULFAMETHOXAZOLE

D. Renlund, E. Hammond, M. Bristow, 1993, Transplantation.

Influence of Number of CAG Repeats on Local Control in the RTOG 86-10 Protocol

A. Markoe, Milijenko Pilepich, E. Hammond, 2006, American journal of clinical oncology.

Immunohistochemically determined total epidermal growth factor receptor levels not of prognostic value in newly diagnosed glioblastoma multiforme: report from the Radiation Therapy Oncology Group.

K. Ang, W. Curran, M. Mehta, 2005, International journal of radiation oncology, biology, physics.

Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy O

D. Grignon, H. Sandler, Chin-Lee Wu, 2005, International journal of radiation oncology, biology, physics.

Loss of p16 expression is of prognostic significance in locally advanced prostate cancer: an analysis from the Radiation Therapy Oncology Group protocol 86-10.

P. Okunieff, R. Abrams, W. Shipley, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prostate cancer DNA ploidy and response to salvage hormone therapy after radiotherapy with or without short-term total androgen blockade: an analysis of RTOG 8610.

D. Grignon, R. Abrams, K. Fu, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

p53 status and prognosis of locally advanced prostatic adenocarcinoma: a study based on RTOG 8610.

D. Grignon, R. Abrams, F. Sarkar, 1997, Journal of the National Cancer Institute.

Flow cytometric quantification of the proliferation-associated nuclear antigen p105 and DNA content in advanced head & neck cancers: results of RTOG 91-08.

S. McDonald, T. Pajak, J. Cooper, 1994, International journal of radiation oncology, biology, physics.

Reply to G. Sauter et al.

A. Wolff, D. Hayes, E. Hammond, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blunt chest trauma: an experimental model for heart and lung contusion.

E. Hammond, D. Doty, N. Wang, 2003, The Journal of trauma.

Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: results of RTOG 9505.

K. Ang, K. Fu, N. Weidner, 2005, International journal of radiation oncology, biology, physics.

Preliminary report on hormone receptors in the human vocal fold.

E. Hammond, S. Gray, J. Butler, 2000, Journal of voice : official journal of the Voice Foundation.

Increased incidence of Chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease.

M L Woods, J. Carlquist, J. Muhlestein, 1996, Journal of the American College of Cardiology.

Correlation between human epidermal growth factor receptor family (EGFR, HER2, HER3, HER4), phosphorylated Akt (P-Akt), and clinical outcomes after radiation therapy in carcinoma of the cervix.

E. Hammond, D. Shrieve, D. Gaffney, 2005, Gynecologic oncology.

Multivariate predictors of heart transplantation outcomes in the era of chronic mechanical circulatory support.

James W Long, Stavros G Drakos, B. Horne, 2007, The Annals of thoracic surgery.

26: A Randomized Trial of Hyperfractionation Versus Standard Fractionation In T2 Squamous Cell Carcinoma of The Vocal Cord

Christopher U. Jones, K. Ang, T. Pajak, 2006 .

Analysis of 1p, 19q, 9p, and 10q as prognostic markers for high-grade astrocytomas using fluorescence in situ hybridization on tissue microarrays from Radiation Therapy Oncology Group trials.

D. Brat, W. Curran, M. Mehta, 2004, Neuro-oncology.

Assessment of Epidermal Growth Factor Receptor (EGFR) expression in human meningioma

T. Hyslop, A. Dicker, E. Hammond, 2010, Radiation oncology.

Cardiac paraprotein associated with Waldenstrom's macroglobulinemia: a case report.

E. Hammond, R. Yowell, 1994, Ultrastructural Pathology.

Detection of allograft endothelial cells of recipient origin following ABO-compatible, nonidentical cardiac transplantation.

D. Renlund, E. Hammond, M. Bristow, 1991, Transplantation.

Expression of HER2neu (c-erbB-2) and epidermal growth factor receptor in cervical cancer: prognostic correlation with clinical characteristics, and comparison of manual and automated imaging analysis.

E. Hammond, D. Gaffney, A. Tsodikov, 2004, Gynecologic oncology.

The role of pathologists in cancer patient staging. Cancer Committee.

D. Henson, E. Hammond, 1995, American journal of clinical pathology.

200 Does Prolonged Continuous-Flow LVAD Unloading Induce Hypertrophy Regression to the Point of Atrophy in the Failing Human Heart?

Dean Y. Li, A. Kfoury, O. Wever-Pinzon, 2012 .

P105 as a prognostic indicator in patients irradiated for locally advanced head-and-neck cancer: a clinical/laboratory correlative analysis of RTOG-9003.

Christopher U. Jones, K. Ang, K. Fu, 2003, International journal of radiation oncology, biology, physics.

Benign pathologic responses of the larynx.

E. Hammond, S. Gray, D. Hanson, 1997, The Annals of otology, rhinology, and laryngology.

Pathology of the Mediastinum

E. Hammond, R. Flinner, 1990 .

Consensus statements on radiation therapy of prostate cancer: guidelines for prostate re-biopsy after radiation and for radiation therapy with rising prostate-specific antigen levels after radical prostatectomy. American Society for Therapeutic Radiology and Oncology Consensus Panel.

P. Schellhammer, R. Kaplan, E. Hammond, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ki-67 is an independent predictor of metastasis and cause-specific mortality for prostate cancer patients treated on Radiation Therapy Oncology Group (RTOG) 94-08.

Christopher U. Jones, M. Ritter, M. Amin, 2013, International journal of radiation oncology, biology, physics.

Evaluation of ki-67 staining levels as an independent biomarker of biochemical recurrence after salvage radiation therapy for prostate cancer.

M. Heckman, T. Pisansky, E. Hammond, 2009, International journal of radiation oncology, biology, physics.

Relationship of Myocardial Fibrosis with the Potential of Mechanical Unloading to Induce Favorable Cardiac Structural and Functional Response

Dean Y. Li, A. Kfoury, O. Wever-Pinzon, 2016 .

Current status of tissue markers as prognostic factors in prostatic adenocarcinoma.

D. Grignon, E. Hammond, 1995, International journal of radiation oncology, biology, physics.

Bcl-2 and Bax Expression Predict Prostate Cancer Outcome in Men Treated with Androgen Deprivation and Radiotherapy on Radiation Therapy Oncology Group Protocol 92-02

H. Sandler, M. Ritter, W. Shipley, 2007, Clinical Cancer Research.

Protein kinase A RI-alpha predicts for prostate cancer outcome: analysis of radiation therapy oncology group trial 86-10.

D. Grignon, H. Sandler, K. Bae, 2008, International journal of radiation oncology, biology, physics.

The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

K. Ang, W. Curran, Meihua Wang, 2008, Radiation oncology.

The utility of circulating donor specific antibody to predict biopsy-proven antibody-mediated rejection and to provide prognostic value after heart transplantation in children

A. Kfoury, E. Hammond, J. Stehlik, 2015 .

Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.

J. Carlquist, E. Hammond, J. Anderson, 1994, Immunology.

Efficacy of OKT3 retreatment for refractory cardiac allograft rejection.

D. Renlund, E. Hammond, M. Bristow, 1989, Transplantation.

Solid Organ Transplantation Pathology

E. Hammond, 1994 .

Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damage.

J. Port, E. Hammond, W. Abraham, 1995, Circulation.

Propagation and characterization of lymphocytes from rejecting human cardiac allografts.

J. Carlquist, E. Hammond, Jeffrey L. Anderson, 1988, The Journal of heart transplantation.

Histone deacetylase inhibitors induce G2-checkpoint arrest and apoptosis in cisplatinum-resistant ovarian cancer cells associated with overexpression of the Bcl-2–related protein Bad

E. Hammond, K. Strait, S. Ilstrup, 2005, Molecular Cancer Therapeutics.

Vascular HLA-DR expression correlates with pathologic changes suggestive of ischemia in idiopathic dilated cardiomyopathy.

E. Hammond, J. Anderson, R. Menlove, 1993, Clinical immunology and immunopathology.